J. Lipid Res.  Neurobiology of Lipids (ISSN1683-5506)
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liscum, L.
Right arrow Articles by Agler, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liscum, L.
Right arrow Articles by Agler, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 43, 1708-1717, October 2002
Copyright © 2002 by Lipid Research, Inc.

Identification of a pharmaceutical compound that partially corrects the Niemann-Pick C phenotype in cultured cells

Laura Liscum1,*, Emily Arnio*, Monique Anthony{dagger}, Andrea Howley§, Stephen L. Sturley§ and Michele Agler{dagger}

* Department of Physiology, Tufts University School of Medicine, Boston, MA 02111
{dagger} Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, Connecticut 06492
§ Institute of Human Nutrition,, Columbia University, New York, NY 10032

1 To whom correspondence should be addressed. e-mail: laura.liscum{at}tufts.edu

Niemann-Pick C (NPC) is an autosomal recessive lysosomal lipid storage disease characterized by progressive central nervous system degeneration. In cultured human NPC fibroblasts, LDL-derived cholesterol accumulates in lysosomes and endosomes, LDL-cholesterol transport from endocytic compartments to other cellular compartments is delayed, and LDL does not elicit normal homeostatic responses. Currently, there is no therapy that delays the onset of neurological symptoms or prolongs the life span of NPC children. We have developed and implemented an amphotericin B-mediated cytotoxicity assay to screen for potential therapeutic drugs that induce cholesterol movement in cultured NPC cells. NPC cells are relatively resistant to amphotericin B killing due to intracellular sequestration of cellular cholesterol. The screen was carried out using simian virus 40-transformed ovarian granulosa cells from the npc nih mouse model of NPC disease. A library of 44,240 compounds was screened and 55 compounds were identified that promote amphotericin B-mediated killing of NPC cells.

One compound, NP-27, corrected the NPC phenotype by four different measures of cholesterol homeostasis. In addition to making NPC cells more sensitive to amphotericin B, NP-27 stimulated two separate cholesterol transport pathways and restored LDL stimulation of cholesterol esterification to near normal levels.

Abbreviations: [3H]CL-LDL, LDL labeled with [3H]cholesteryl linoleate; FCLPDS, fetal calf lipoprotein-deficient serum; MTT, 3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide; NPC, Niemann-Pick disease type C

Supplementary key words Niemann-Pick C • cholesterol • high throughput screen • cholesterol transport • amphotericin B


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
I. Delton-Vandenbroucke, J. Bouvier, A. Makino, N. Besson, J.-F. Pageaux, M. Lagarde, and T. Kobayashi
Anti-bis(monoacylglycero)phosphate antibody accumulates acetylated LDL-derived cholesterol in cultured macrophages
J. Lipid Res., March 1, 2007; 48(3): 543 - 552.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
N. H. Pipalia, A. Huang, H. Ralph, M. Rujoi, and F. R. Maxfield
Automated microscopy screening for compounds that partially revert cholesterol accumulation in Niemann-Pick C cells
J. Lipid Res., February 1, 2006; 47(2): 284 - 301.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. A. F. von Arnim, A. Kinoshita, I. D. Peltan, M. M. Tangredi, L. Herl, B. M. Lee, R. Spoelgen, T. T. Hshieh, S. Ranganathan, F. D. Battey, et al.
The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel {beta}-Secretase (BACE1) Substrate
J. Biol. Chem., May 6, 2005; 280(18): 17777 - 17785.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
N. Y. Gevry, F. L. Lopes, S. Ledoux, and B. D. Murphy
Aberrant Intracellular Cholesterol Transport Disrupts Pituitary and Ovarian Function
Mol. Endocrinol., July 1, 2004; 18(7): 1778 - 1786.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.